Investment Summary

Polaris Partners Invests In ByHeart

On April 15, 2020, growth capital firm Polaris Partners invested in consumer products company ByHeart

Investment Highlights
  • This is Polaris Partners’ 2nd transaction in the Consumer Products sector.
  • This is Polaris Partners’ 56th transaction in the United States.
  • This is Polaris Partners’ 10th transaction in New York.

Investment Summary
Date 2020-04-15
Target ByHeart
Sector Consumer Products
Investor(s) Polaris Partners
Deal Type Venture

Target

ByHeart

New York, New York, United States
ByHeart is a next-generation baby nutrition company dedicated to empowering parents with choices for a better feeding future. ByHeart was founded in 2016 and is based in New York City.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Investor(S) 1

Investor

Polaris Partners

Investor Investor Investor Investor Investor

Category Growth Capital Firm
Founded 1996
PE ASSETS 5.0B USD
Size Large
Type Sector Agnostic
DESCRIPTION

Polaris Partners is primarily a seed, first round, and early stage venture capital investor in information technology and life science businesses. However, Polaris also focuses on private equity investments in established companies. In this area, Polaris targets high growth middle market companies in industries including technology, healthcare, digital media, consumer products and services, and business services. The firm's investments include minority growth equity investments, recapitalizations with liquidity, and leveraged buyouts. Polaris Partners was formed in 1996 and has offices in Seattle, Washington and Waltham, Massachusetts.

DEAL STATS #
Overall 59 of 87
Sector (Consumer Products) 2 of 3
Type (Venture) 31 of 57
State (New York) 10 of 13
Country (United States) 56 of 78
Year (2020) 3 of 8
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2020-03-02 Primmune Therapeutics

San Diego, California, United States

Primmune Therapeutics is harnessing the power of the innate immune system to develop immunotherapies for the treatment of cancer and viral diseases. Primmune Therapeutics was founded in 2017 and is based in San Diego, California.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2020-05-01 Wellthy

New York, New York, United States

Wellthy is a medical concierge that helps individuals and employees to manage the complexities of healthcare while caring for a loved one. From managing medications, deciding about treatment options, managing appointments and doctors, not to mention dealing with the financial, insurance, and long term implications, the healthcare maze is simply too complicated. Wellthy was founded in 2014 and is based in New York.

Buy -
Mergr

Product

Company

Legal